The global market for New Shingles Vaccine was valued at US$ 1230 million in the year 2024 and is projected to reach a revised size of US$ 1556 million by 2031, growing at a CAGR of 3.5% during the forecast period.

New Shingles Vaccine Market

The new shingles vaccine is a vaccine used to prevent herpes zoster (commonly known as "shingles"), which mainly stimulates the immune system to produce antibodies against the varicella-zoster virus (VZV), thereby reducing the risk of shingles infection in the elderly and those with weakened immunity, and reducing the pain and complications caused by the disease. This vaccine usually contains highly effective active ingredients that can significantly enhance the body's immune response, is more effective than traditional vaccines, and can provide long-term protection, especially for people over 50 years old.

North American market for New Shingles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for New Shingles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of New Shingles Vaccine include Pfizer, GSK, Merck, Sanofi, Novartis, Yidao Biotechnology, Jiangsu Ruike Biotechnology, Beijing Luzhu Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for New Shingles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Shingles Vaccine.

The New Shingles Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Shingles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the New Shingles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of New Shingles Vaccine Market Report

Report Metric	Details
Report Name	New Shingles Vaccine Market
Accounted market size in year	US$ 1230 million
Forecasted market size in 2031	US$ 1556 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Live Attenuated Vaccines Recombinant Vaccines
Segment by Application	Subcutaneous Vaccines Intradermal Vaccines
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, GSK, Merck, Sanofi, Novartis, Yidao Biotechnology, Jiangsu Ruike Biotechnology, Beijing Luzhu Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of New Shingles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of New Shingles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is New Shingles Vaccine Market growing?

Ans: The New Shingles Vaccine Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the New Shingles Vaccine Market size in 2031?

Ans: The New Shingles Vaccine Market size in 2031 will be US$ 1556 million.

Who are the main players in the New Shingles Vaccine Market report?

Ans: The main players in the New Shingles Vaccine Market are Pfizer, GSK, Merck, Sanofi, Novartis, Yidao Biotechnology, Jiangsu Ruike Biotechnology, Beijing Luzhu Biotechnology

What are the Application segmentation covered in the New Shingles Vaccine Market report?

Ans: The Applications covered in the New Shingles Vaccine Market report are Subcutaneous Vaccines, Intradermal Vaccines

What are the Type segmentation covered in the New Shingles Vaccine Market report?

Ans: The Types covered in the New Shingles Vaccine Market report are Live Attenuated Vaccines, Recombinant Vaccines

1 New Shingles Vaccine Market Overview

1.1 Product Definition

1.2 New Shingles Vaccine by Type

1.2.1 Global New Shingles Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Live Attenuated Vaccines

1.2.3 Recombinant Vaccines

1.3 New Shingles Vaccine by Application

1.3.1 Global New Shingles Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Subcutaneous Vaccines

1.3.3 Intradermal Vaccines

1.4 Global New Shingles Vaccine Market Size Estimates and Forecasts

1.4.1 Global New Shingles Vaccine Revenue 2020-2031

1.4.2 Global New Shingles Vaccine Sales 2020-2031

1.4.3 Global New Shingles Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 New Shingles Vaccine Market Competition by Manufacturers

2.1 Global New Shingles Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global New Shingles Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global New Shingles Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of New Shingles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of New Shingles Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of New Shingles Vaccine, Product Type & Application

2.7 Global Key Manufacturers of New Shingles Vaccine, Date of Enter into This Industry

2.8 Global New Shingles Vaccine Market Competitive Situation and Trends

2.8.1 Global New Shingles Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest New Shingles Vaccine Players Market Share by Revenue

2.8.3 Global New Shingles Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global New Shingles Vaccine Market Scenario by Region

3.1 Global New Shingles Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global New Shingles Vaccine Sales by Region: 2020-2031

3.2.1 Global New Shingles Vaccine Sales by Region: 2020-2025

3.2.2 Global New Shingles Vaccine Sales by Region: 2026-2031

3.3 Global New Shingles Vaccine Revenue by Region: 2020-2031

3.3.1 Global New Shingles Vaccine Revenue by Region: 2020-2025

3.3.2 Global New Shingles Vaccine Revenue by Region: 2026-2031

3.4 North America New Shingles Vaccine Market Facts & Figures by Country

3.4.1 North America New Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America New Shingles Vaccine Sales by Country (2020-2031)

3.4.3 North America New Shingles Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe New Shingles Vaccine Market Facts & Figures by Country

3.5.1 Europe New Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe New Shingles Vaccine Sales by Country (2020-2031)

3.5.3 Europe New Shingles Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific New Shingles Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific New Shingles Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific New Shingles Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific New Shingles Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America New Shingles Vaccine Market Facts & Figures by Country

3.7.1 Latin America New Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America New Shingles Vaccine Sales by Country (2020-2031)

3.7.3 Latin America New Shingles Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa New Shingles Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa New Shingles Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa New Shingles Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa New Shingles Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global New Shingles Vaccine Sales by Type (2020-2031)

4.1.1 Global New Shingles Vaccine Sales by Type (2020-2025)

4.1.2 Global New Shingles Vaccine Sales by Type (2026-2031)

4.1.3 Global New Shingles Vaccine Sales Market Share by Type (2020-2031)

4.2 Global New Shingles Vaccine Revenue by Type (2020-2031)

4.2.1 Global New Shingles Vaccine Revenue by Type (2020-2025)

4.2.2 Global New Shingles Vaccine Revenue by Type (2026-2031)

4.2.3 Global New Shingles Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global New Shingles Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global New Shingles Vaccine Sales by Application (2020-2031)

5.1.1 Global New Shingles Vaccine Sales by Application (2020-2025)

5.1.2 Global New Shingles Vaccine Sales by Application (2026-2031)

5.1.3 Global New Shingles Vaccine Sales Market Share by Application (2020-2031)

5.2 Global New Shingles Vaccine Revenue by Application (2020-2031)

5.2.1 Global New Shingles Vaccine Revenue by Application (2020-2025)

5.2.2 Global New Shingles Vaccine Revenue by Application (2026-2031)

5.2.3 Global New Shingles Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global New Shingles Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer New Shingles Vaccine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GSK New Shingles Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merck New Shingles Vaccine Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Company Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sanofi New Shingles Vaccine Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 Novartis

6.5.1 Novartis Company Information

6.5.2 Novartis Description and Business Overview

6.5.3 Novartis New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Novartis New Shingles Vaccine Product Portfolio

6.5.5 Novartis Recent Developments/Updates

6.6 Yidao Biotechnology

6.6.1 Yidao Biotechnology Company Information

6.6.2 Yidao Biotechnology Description and Business Overview

6.6.3 Yidao Biotechnology New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Yidao Biotechnology New Shingles Vaccine Product Portfolio

6.6.5 Yidao Biotechnology Recent Developments/Updates

6.7 Jiangsu Ruike Biotechnology

6.7.1 Jiangsu Ruike Biotechnology Company Information

6.7.2 Jiangsu Ruike Biotechnology Description and Business Overview

6.7.3 Jiangsu Ruike Biotechnology New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Jiangsu Ruike Biotechnology New Shingles Vaccine Product Portfolio

6.7.5 Jiangsu Ruike Biotechnology Recent Developments/Updates

6.8 Beijing Luzhu Biotechnology

6.8.1 Beijing Luzhu Biotechnology Company Information

6.8.2 Beijing Luzhu Biotechnology Description and Business Overview

6.8.3 Beijing Luzhu Biotechnology New Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beijing Luzhu Biotechnology New Shingles Vaccine Product Portfolio

6.8.5 Beijing Luzhu Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 New Shingles Vaccine Industry Chain Analysis

7.2 New Shingles Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 New Shingles Vaccine Production Mode & Process Analysis

7.4 New Shingles Vaccine Sales and Marketing

7.4.1 New Shingles Vaccine Sales Channels

7.4.2 New Shingles Vaccine Distributors

7.5 New Shingles Vaccine Customer Analysis

8 New Shingles Vaccine Market Dynamics

8.1 New Shingles Vaccine Industry Trends

8.2 New Shingles Vaccine Market Drivers

8.3 New Shingles Vaccine Market Challenges

8.4 New Shingles Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Jiangsu Ruike Biotechnology

Beijing Luzhu Biotechnology

List of Tables

Table 1. Global New Shingles Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global New Shingles Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global New Shingles Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global New Shingles Vaccine Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global New Shingles Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global New Shingles Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global New Shingles Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market New Shingles Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of New Shingles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of New Shingles Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of New Shingles Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of New Shingles Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global New Shingles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Shingles Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global New Shingles Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global New Shingles Vaccine Sales by Region (2020-2025) & (Units)

Table 18. Global New Shingles Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global New Shingles Vaccine Sales by Region (2026-2031) & (Units)

Table 20. Global New Shingles Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global New Shingles Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global New Shingles Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global New Shingles Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global New Shingles Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America New Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America New Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 27. North America New Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 28. North America New Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America New Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe New Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe New Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 32. Europe New Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 33. Europe New Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe New Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific New Shingles Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific New Shingles Vaccine Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific New Shingles Vaccine Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific New Shingles Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific New Shingles Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America New Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America New Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 42. Latin America New Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 43. Latin America New Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America New Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa New Shingles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa New Shingles Vaccine Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa New Shingles Vaccine Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa New Shingles Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa New Shingles Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global New Shingles Vaccine Sales (Units) by Type (2020-2025)

Table 51. Global New Shingles Vaccine Sales (Units) by Type (2026-2031)

Table 52. Global New Shingles Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global New Shingles Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global New Shingles Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global New Shingles Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global New Shingles Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global New Shingles Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global New Shingles Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global New Shingles Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global New Shingles Vaccine Sales (Units) by Application (2020-2025)

Table 61. Global New Shingles Vaccine Sales (Units) by Application (2026-2031)

Table 62. Global New Shingles Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global New Shingles Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global New Shingles Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global New Shingles Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global New Shingles Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global New Shingles Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global New Shingles Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global New Shingles Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer New Shingles Vaccine Product

Table 74. Pfizer Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. GSK New Shingles Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Merck New Shingles Vaccine Product

Table 84. Merck Recent Developments/Updates

Table 85. Sanofi Company Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Sanofi New Shingles Vaccine Product

Table 89. Sanofi Recent Developments/Updates

Table 90. Novartis Company Information

Table 91. Novartis Description and Business Overview

Table 92. Novartis New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Novartis New Shingles Vaccine Product

Table 94. Novartis Recent Developments/Updates

Table 95. Yidao Biotechnology Company Information

Table 96. Yidao Biotechnology Description and Business Overview

Table 97. Yidao Biotechnology New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Yidao Biotechnology New Shingles Vaccine Product

Table 99. Yidao Biotechnology Recent Developments/Updates

Table 100. Jiangsu Ruike Biotechnology Company Information

Table 101. Jiangsu Ruike Biotechnology Description and Business Overview

Table 102. Jiangsu Ruike Biotechnology New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Jiangsu Ruike Biotechnology New Shingles Vaccine Product

Table 104. Jiangsu Ruike Biotechnology Recent Developments/Updates

Table 105. Beijing Luzhu Biotechnology Company Information

Table 106. Beijing Luzhu Biotechnology Description and Business Overview

Table 107. Beijing Luzhu Biotechnology New Shingles Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Beijing Luzhu Biotechnology New Shingles Vaccine Product

Table 109. Beijing Luzhu Biotechnology Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. New Shingles Vaccine Distributors List

Table 113. New Shingles Vaccine Customers List

Table 114. New Shingles Vaccine Market Trends

Table 115. New Shingles Vaccine Market Drivers

Table 116. New Shingles Vaccine Market Challenges

Table 117. New Shingles Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of New Shingles Vaccine

Figure 2. Global New Shingles Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global New Shingles Vaccine Market Share by Type: 2024 & 2031

Figure 4. Live Attenuated Vaccines Product Picture

Figure 5. Recombinant Vaccines Product Picture

Figure 6. Global New Shingles Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global New Shingles Vaccine Market Share by Application: 2024 & 2031

Figure 8. Subcutaneous Vaccines

Figure 9. Intradermal Vaccines

Figure 10. Global New Shingles Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global New Shingles Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global New Shingles Vaccine Sales (2020-2031) & (Units)

Figure 13. Global New Shingles Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. New Shingles Vaccine Report Years Considered

Figure 15. New Shingles Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global New Shingles Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest New Shingles Vaccine Players: Market Share by Revenue in New Shingles Vaccine in 2024

Figure 18. New Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global New Shingles Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America New Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America New Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe New Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe New Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific New Shingles Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific New Shingles Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America New Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America New Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Colombia New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa New Shingles Vaccine Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa New Shingles Vaccine Revenue Market Share by Country (2020-2031)

Figure 48. Turkey New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE New Shingles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of New Shingles Vaccine by Type (2020-2031)

Figure 52. Global Revenue Market Share of New Shingles Vaccine by Type (2020-2031)

Figure 53. Global New Shingles Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of New Shingles Vaccine by Application (2020-2031)

Figure 55. Global Revenue Market Share of New Shingles Vaccine by Application (2020-2031)

Figure 56. Global New Shingles Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 57. New Shingles Vaccine Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions